ARGONAUTICA PRIVATE WEALTH MANAGEMENT, INC

Position in NVO — Novo Nordisk A S

CIK 1931870 WELLESLEY, MA

Position in NVO

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,035,551

+$496,613 QoQ

Shares Held

21,601

+47.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#520

of 1,348 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARGONAUTICA PRIVATE WEALTH MANAGEMENT, INC holds $10,577,031 across 6 Drug Manufacturers - General names. NVO ranks #4 (9.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	14,639	$3,683,757
2	LLY	ELI LILLY & Co	2,835	$3,400,384
3	JNJ	Johnson & Johnson	5,045	$1,281,278
4	NVO	Novo Nordisk A S This page	21,601	$1,035,551
5	MRK	Merck & Co., Inc.	5,715	$734,377
6	GILD	Gilead Sciences, Inc.	3,496	$441,684

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,035,551	21,601	+47.3%	Shares	Sole	2026-07-28
2026-03-31	$538,938	14,665	+15.8%	Shares	Sole	2026-04-28
2025-12-31	$644,191	12,661	+46.0%	Shares	Sole	2026-02-11
2025-09-30	$481,153	8,671	+6.9%	Shares	Sole	2025-10-23
2025-06-30	$559,890	8,112	-1.0%	Shares	Sole	2025-07-30
2025-03-31	$568,713	8,190	+9.7%	Shares	Sole	2025-05-06
2024-12-31	$642,053	7,464	-0.4%	Shares	Sole	2025-02-05
2024-09-30	$891,953	7,491	+0.6%	Shares	Sole	2024-10-29
2024-06-30	$1,063,127	7,448	-0.0%	Shares	Sole	2024-07-26
2024-03-31	$956,451	7,449	+28.6%	Shares	Sole	2024-04-30
2023-12-31	$599,389	5,794	-0.3%	Shares	Sole	2024-02-02
2023-09-30	$528,543	5,812	+100.8%	Shares	Sole	2023-11-07
2023-06-30	$468,336	2,894	+18.9%	Shares	Sole	2023-08-03
2023-03-31	$387,187	2,433	-19.0%	Shares	Sole	2023-05-04
2022-12-31	$406,561	3,004	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.